Premier Alternatives

Inversion Therapeutics

Burlingame, CA · Founded 2025 · Privately Held (backing)

Developer of an oncology biotech platform designed to discover and progress therapies against previously untapped cancer mechanisms. Inversion Therapeutics is based in Burlingame, CA and was founded in 2025. It was valued at $17 million at its seed round in Aug 2025, the last priced event on record. It has raised $6.9 million across 1 recorded round; the latest was a $6.9 million early-stage round in Jun 2025.

PMV mark · valuation
$17.0M
Oct 2026
Priced at
its seed round
Aug 2025
Total raised
$6.9M
Last round
Early Stage VC
Jun 2025

Inversion Therapeutics key facts

as of Oct 2026
  • Developer of an oncology biotech platform designed to discover and progress therapies against previously untapped cancer mechanisms.
  • Inversion Therapeutics is valued at approximately $17.0M as of Oct 2026, set at its seed round, Aug 2025; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $6.9M across 1 recorded rounds; the latest was Early Stage VC ($6.9M) in Jun 2025.
  • Notable investors include Red Tree Venture Capital.
  • Inversion Therapeutics has filed 1 Form D with the SEC, most recently Aug 2025 ($6.9M sold to 4 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$17.0M

Valued at $17.0M at its seed round, Aug 2025. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Inversion Therapeutics with a free account
  • ·Watch Inversion Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Inversion Therapeutics funding rounds

1 rounds
Jun 2025Early Stage VC$6.9MSEC filing▮
Full funding history →

Who backs Inversion Therapeutics

1
Red Tree Venture Capital

Inversion Therapeutics valuation

Inversion Therapeutics was valued at $17 million at its seed round in Aug 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Inversion Therapeutics raised?

Inversion Therapeutics has raised $6.9 million across 1 recorded round since 2025. The largest was a $6.9 million early-stage round in Jun 2025.

Inversion Therapeutics has filed 1 Form D with the SEC, most recently in Aug 2025 ($6.9 million sold to 4 investors).

Inversion Therapeutics investors

1 investor is on record for Inversion Therapeutics, including Red Tree Venture Capital. By type, the record holds 1 venture capital firm. The early-stage round in Jun 2025 drew 4 investors.

About Inversion Therapeutics

Developer of an oncology biotech platform designed to discover and progress therapies against previously untapped cancer mechanisms. The company is currently operating in Stealth mode.

Sector
Healthcare
HQ
Burlingame, CA, United States
Founded
2025
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.